Announcing our newest cancer test. Screen cancer early with Onco-D-clare. Learn more

Blog

June 22, 2024
Beyond CBCs: Advanced blood tests for detecting cancer
The number of new cancer cases diagnosed each year is staggering. In 2024, there will be an estimated 2 million new cases of cancer in the United States. Early detection is crucial, as it can significantly increase survival rates and improve treatment outcomes.
Read More
May 20, 2024
Is my cancer coming back? How blood tests offer early warning signs.
The fear of cancer recurrence is a very real concern for many cancer survivors. Once treatment is complete and you have achieved remission, the possibility of the cancer returning can cause significant anxiety.
Read More
April 15, 2024
Compare our tests
At RGCC, our scientists use world-leading technology, equipment, and innovative techniques to develop a range of cancer screening and monitoring tests. Our tests help cancer patients and their healthcare professionals get a comprehensive but personalized view of each patient’s genetics, physiology, and immune profiles.
Read More
April 8, 2024
Understanding your cancer: How advanced blood tests empower treatment choices
If you or a loved one has a cancer diagnosis, you're likely flooded with information about treatment options. While traditional biopsies remain crucial for definitive diagnosis, a new wave of innovation is transforming the landscape of cancer care.
Read More
March 26, 2024
How to reduce breast cancer risk
It is possible to reduce breast cancer risk significantly by understanding the factors that contribute to it and taking proactive steps against them. Whether you're seeking preventive measures for yourself or advocating for a loved one, arming yourself with information is the first step towards reducing breast cancer risk and boosting overall well-being.
Read More
March 21, 2024
What is the Onconomics Plus test?
The RGCC Onconomics Plus test is our pioneering step beyond the standard approach to cancer testing and cancer care. The level of intricate genetic information uncovered by this test is unparalleled in the cancer care realm.
Read More
1 2 3
Follow Us
Accreditations
IAS Accreditation
Testing Laboratory
View TL-836 Certificate
EN ISO 22000: 2018
No: 20101200002689
View Certificate
IAS Accreditation
Medical Laboratory
View ML-103 Certificate
ISO 22000: 2018
No: 20101200002689
View Certificate
ISO 45001: 2018
No: 20152220006395
View CertificatePolicy
ISO 22716: 2007
No: 20019220006394
View Certificate
CLIA ID Number
99D2283882
View Certificate
College of American Pathologists 
Certificate of Accreditation
CAP#: 9239089 
CLIA#: 99D2283882 
View Certificate
Certificate of GMP Compliance
No. 512863-102689104
View Certificate
Accreditation Certificate of Foreign Cell Processor - Japanese Government
View Certificate
EOF GMP COSMETICS – SUPPLEMENTS
View Certificate
Accreditations
IAS Accreditation
Testing Laboratory
View TL-836 Certificate
EN ISO 22000: 2018
No: 20101200002689
View Certificate
IAS Accreditation
Medical Laboratory
View ML-103 Certificate
ISO 22000: 2018
No: 20101200002689
View Certificate
ISO 45001: 2018
No: 20152220006395
View CertificatePolicy
ISO 22716: 2007
No: 20019220006394
View Certificate
CLIA ID Number
99D2283882
View Certificate
College of American Pathologists 
Certificate of Accreditation
CAP#: 9239089 
CLIA#: 99D2283882 
View Certificate
Certificate of GMP Compliance
No. 512863-102689104
View Certificate
Accreditation Certificate of Foreign Cell Processor - Japanese Government
View Certificate
EOF GMP COSMETICS – SUPPLEMENTS
View Certificate
Call
Text
Email
Map